DeLap RJ - Search Results

1

Phase I/pharmacokinetic reevaluation of thioTEPA.

O'Dwyer PJ, LaCreta F, Engstrom PF, Peter R, Tartaglia L, Cole D, Litwin S, DeVito J, Poplack D, DeLap RJ, et al. O'Dwyer PJ, et al. Among authors: delap rj. Cancer Res. 1991 Jun 15;51(12):3171-6. Cancer Res. 1991. PMID: 1710167 Clinical Trial.

2

Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil.

Hudes GR, LaCreta F, DeLap RJ, Grillo-Lopez AJ, Catalano R, Comis RL. Hudes GR, et al. Among authors: delap rj. Cancer Chemother Pharmacol. 1989;24(2):117-22. doi: 10.1007/BF00263132. Cancer Chemother Pharmacol. 1989. PMID: 2525077

3

Trimetrexate: clinical development of a nonclassical antifolate.

O'Dwyer PJ, DeLap RJ, King SA, Grillo-Lopez AJ, Hoth DF, Leyland-Jones B. O'Dwyer PJ, et al. Among authors: delap rj. NCI Monogr. 1987;(5):105-9. NCI Monogr. 1987. PMID: 2963228

4

Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokinetics.

Lin JT, Cashmore AR, Baker M, Dreyer RN, Ernstoff M, Marsh JC, Bertino JR, Whitfield LR, Delap R, Grillo-Lopez A. Lin JT, et al. Cancer Res. 1987 Jan 15;47(2):609-16. Cancer Res. 1987. PMID: 2947679

5

Bioequivalence of two leucovorin calcium tablet formulations.

De Vito JM, McGuire BW, De Lap RJ, Weiss AI. De Vito JM, et al. DICP. 1989 Feb;23(2):153-4. doi: 10.1177/106002808902300210. DICP. 1989. PMID: 2786292 Clinical Trial.

6

Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.

Marshall JL, Wellstein A, Rae J, DeLap RJ, Phipps K, Hanfelt J, Yunmbam MK, Sun JX, Duchin KL, Hawkins MJ. Marshall JL, et al. Among authors: delap rj. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2347-54. Clin Cancer Res. 1997. PMID: 9815633 Clinical Trial.

7

Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine.

Marshall JL, Richmond E, DeLap RJ. Marshall JL, et al. Among authors: delap rj. Clin Cancer Res. 1996 Sep;2(9):1475-80. Clin Cancer Res. 1996. PMID: 9816323

8

The effect of leucovorin on the therapeutic index of fluorouracil in cancer patients.

DeLap RJ. DeLap RJ. Yale J Biol Med. 1988 Jan-Feb;61(1):23-34. Yale J Biol Med. 1988. PMID: 3284210 Free PMC article. Review.

9

An alternate method to overcoming central venous catheter blockage in patients receiving high-dose fluorouracil and leucovorin.

Marshall JL, DeLap RJ. Marshall JL, et al. Among authors: delap rj. J Clin Oncol. 1993 Jul;11(7):1433-4. doi: 10.1200/JCO.1993.11.7.1433. J Clin Oncol. 1993. PMID: 8315442 No abstract available.

10

Clinical pharmacokinetics and pharmacology of trimetrexate.

Marshall JL, DeLap RJ. Marshall JL, et al. Among authors: delap rj. Clin Pharmacokinet. 1994 Mar;26(3):190-200. doi: 10.2165/00003088-199426030-00003. Clin Pharmacokinet. 1994. PMID: 8194282 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page